SCHEMBL2256748

SCHEMBL2256748

Cc1cc(OCCN(C)C)ccc1-c1cccc2cnc(NC3CCC(O)CC3)nc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 5/20 0.55
JUN P05412 2/20 0.55
RIPK2 O43353 1/20 0.42
ADORA1 P30542 3/20 0.40
ADORA2A P29274 2/20 0.40
ADORA2B P29275 1/20 0.40
BRAF P15056 1/20 0.39
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
FLT3 P36888 1/20 0.37
TYRO3 Q06418 1/20 0.37
MERTK Q12866 1/20 0.37
GAS6 Q14393 1/20 0.37
MAPK8 P45983 5/20 0.37
MAPK9 P45984 3/20 0.37
PDK2 Q15119 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL557479 1.00 MAPK10 (0.55) MAPK10JUNRIPK2ADORA1ADORA2A
SCHEMBL558818 0.87 MAPK10 (0.64) MAPK10JUNRIPK2ADORA1ADORA2A
SCHEMBL558817 0.87 MAPK10 (0.64) MAPK10JUNRIPK2ADORA1ADORA2A
SCHEMBL12378898 0.81 MAPK10 (0.54) MAPK10JUNADORA1ADORA2AADORA2B
SCHEMBL558933 0.80 MAPK10 (0.72) MAPK10JUNRIPK2ADORA1ADORA2A
SCHEMBL558932 0.80 MAPK10 (0.72) MAPK10JUNRIPK2ADORA1ADORA2A
SCHEMBL558641 0.79 MAPK8 (0.45) MAPK10JUNRIPK2ADORA1ADORA2A
SCHEMBL558642 0.79 MAPK8 (0.45) MAPK10JUNRIPK2ADORA1ADORA2A
SCHEMBL3492933 0.78 MAPK10 (0.59) MAPK10JUNRIPK2ADORA1ADORA2A
SCHEMBL559197 0.75 MAPK10 (0.66) MAPK10JUNRIPK2ADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 US disclosed
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS MAPK1, SLC5A1, ATF1 MAPK10 32/4885JUN 36/4885RIPK2 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.